Between 2000 and 2050, the United Nations predicts that the number of individuals living with dementia in developed nations will rise from 13.5 million to 36.7 million. In the United States, there are around 4 million people living with dementia. Alzheimer's disease is the most common form of dementia, accounting for 50% to 70% of all cases and over 100,000 deaths each year. Alzheimer's disease prevalence and incidence rise with age, seemingly doubling every 5 years after the age of 60 and due of the significant link between age and Alzheimer's disease, researchers believe that biological processes linked with ageing may play a role in the disease's development, but that genetic, psychological, and environmental risk factors modify the disease's age-specific rates.
- Recent Findings and Treatments
- Pharmacologic Approaches
Jun Hua
Johns Hopkins University , United States
Nazneen N Dewji
Cenna Biosciences Inc, United States
Jacqueline London
Paris Diderot University, FranceSubmit your abstract Today
Title : Make a difference
Jacqueline Tuppen, Dementia UK, United Kingdom
Title : Imaging brain clearance in Alzheimer’s disease
Jun Hua, Johns Hopkins University , United States
Title : Neuromodulation of scalp electroacupuncture in the treatment of autism spectrum disorder
Zhenhuan Liu, Nanhai Maternity and Children Hospital Affiliated to Guangzhou University of Chinese Medicine, China
Title : Neuroimaging-based evaluation of scalp acupuncture for neural repair and reorganization in children with cerebral palsy
Zhenhuan Liu, Nanhai Maternity and Children Hospital Affiliated to Guangzhou University of Chinese Medicine, China
Title : Neurophysiological change and cognitive response to levetiracetam in Alzheimer disease: Testing the missing mechanistic link
Christopher Hubler, Emergent Neural Systems Institute for Research, United States
Title : Healthcare professionals in Somaliland had low levels of knowledge and attitudes towards dementia care: A pilot survey
Mohamed Abdilahi Duale, Frantz Fanon University, Somalia